Diagnostic and Biotech

2015-2019 New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • VPG321342
  • 620 Pages
  • August 2015
  • Diagnostic and Biotech
Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400.


2015-2019 New Frontiers in the U.S. Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearchs new study of the major business opportunities emerging in the U.S. cancer diagnostics market during the nextfive years. The report examines trends in the U.S. cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.


U.S. Market Overview


- Five-year test volume and sales projections.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of laboratories performing cancer diagnostic testing.


- Cancer statistics, etiology and recent developments.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.


- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,

Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,

Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,

Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,

Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,

Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,

Tissue Polypeptide Antigen, and others.


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test.


- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics


Instrumentation Review


- Analysis of major molecular diagnostic and immunodiagnostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest molecular diagnostic methods,

biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,

chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies, including

CT, MRI, NMR, PET and photonics spectroscopy.


- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include


- Abbott

- AdnaGen/Alere

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode Genetics

- Diadexus

- Diagnocure

- DiaSorin

- Eiken Chemical


- Elitech Group

- Epigenomics

- Enterix

- Enzo Biochem

- Exact Sciences

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- OncoLab

- Ortho-Clinical Diagnostics

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zilla


Contains 620 pages and 103 tables


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Cell Counting Market - Opportunities and Forecasts, 2015 - 2020

Cell counting is a method of counting cells for medical applications, and plays an important role in research and clinical activities. Cell counts in liquid media is expressed in cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Respiratory Syncytial Virus (RSV) Diagnostic Market (Technology, End Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Respiratory syncytial virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Protein Purification and Isolation Market - Opportunities and Forecasts, 2015 - 2020

Protein purification is the process of isolating proteins from the complex mixtures of cells, tissues, or organisms based on differences in their physical properties. The protein purification process aims to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Medical Image Processing Market (Application, Image Type, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Medical imaging is a technique used for the creating the visual representation of the internal body parts for the purpose of clinical analysis and medical intervention. The use of this technique revels internal structure that is hidden by the skin and bones for the diagnosis and treatment of disease.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Life Science and Chemical Instrumentation Market - Opportunities and Forecasts, 2015 - 2020

Life science and chemical instrumentation is used in research & development activities in industrial laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in testing the quality ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Veterinary Diagnostics Market (Products, Animals, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>